NewswireToday - /newswire/ -
Beverly Hills, CA, United States, 2007/03/08 - Vision Digital Multimedia Corporation announced today that it has completed the acquisition of Clinicares Co., Ltd and has changed its name to Clinicares, Inc. The new stock trading symbol is CCRC (OTC: CCRC).
Through the acquisition of Clinicares Co. Ltd. VDGM is a Biotech Development Stage Company involved in R&D, Manufacturing, Distribution and Marketing its proprietary products in the anti aging, cosmeceutical, and beauty aid fields with both branded and private label activities.
The company’s primary focus and product line is the Microneedle Therapy System or “MTS”, which includes the Micro-Roller consumer product and associated cosmeceutical product line. This product line is aimed at replacing dermabrasion, chemical and laser resurfacing as a new drug delivery system with the micro-roller for clinical and consumer use.
The MTS system is marketed directly to physicians and to consumers via direct marketing globally. It has already enjoyed success on home shopping networks globally and is recognized by numerous cosmetic surgeons as a breakthrough in the industry.
“We are excited about moving forward as a public company and expect to file all requisite reports to become fully reporting in the first quarter of this year” said Clinicares President, Halen Bach.
About the MTS System and Microneedle Therapy
Until now dermabrasion, acid-peeling or laser re-surfacing have one and the same target: to remove the protective epidermis, and set a 2nd degree burn. This forces the dermis to produce a new tissue layer. Once that protective layer against environmental influences such as dirt, bacteria, etc. is removed, certain health risks must be accepted: long prevailing inflammation and redness, long healing period (like on all burns), extreme light-sensitivity over month, possible irreversible pigment changes and scars. Due to different skin structure on the neck and décolleté, a laser re-surfacing is not possible.
The Microneedle Therapy with the Microneedle Roller, is a perfect alternative to achieve the same goal: a new collagen-layer on the dermis. The Microneedle Roller is studded with nearly 200 extreme fine needles of medical grade stainless steel. If these fine needles penetrate the dermis tiny painless micro-wounds are set. The skin reacts to these pricks like it reacts to any other wound with the distribution of the various growth factors. This process of additional production of collagen tissue is a normal physiological reaction and called: Natural-Collagen-Induction. The new collagen develops on top of the dermis and underneath the epidermis. In the course of the next month the collagen is transformed from collagen-type III to type I, resulting in more fiber strength and elasticity.
The "Soft" Alternative for all Common Laser & Peeling-Methods:
MTS (Microneedle Therapy System) is a procedure which stimulates the skin to produce new collagen formation, thereby reducing wrinkles, and improving skin texture. A roller with very fine needles (called the Dermaroller) is used to produce many microscopic channels in the skin, which stimulate your own body to produce new collagen. These channels also improve the penetration of Oxygenating Hexa Peptides 3 (Oxy3 Peptide), vitamin creams, or any other liposomal serums about 1000 times. Oxy3 Peptide stimulates skin renewal, thereby making the skin appear fresher and younger. MTS is different than artificial injected collagen, as the effects of collagen induction activities are long lasting.
About the Company
Through the acquisition of Clinicares Co. Ltd. VDGM is a Biotech development stage company involved in R&D, Manufacturing, Distribution and Marketing its proprietary products in the anti aging, cosmeceutical, and beauty aid fields with both branded and private label activities. Its primary focus and product line is the Microneedle Therapy System (MTS) which includes the Micro-roller consumer product and associated cosmeceutical product line aimed at replacing demabrasion, chemical and laser resurfacing as a new drug delivery system wit the micro-roller for clinical and consumer use. The MTS system is marketed globally directly to physicians and to consumers via direct marketing.